Medicamen Biotech Share price

MEDICAMEQ

Healthcare Small

228.97

2.67 (-1.15%)

NSE

BSE

Last updated on 2 Apr, 2026 | 15:48 IST

BUYSELL

Today's High

239.39

Today's Low

225.01

52 Week Low

216.95

52 Week High

544.00

Free Demat with Zero AMC*

Medicamen Biotech Chart

ChartIQ

TradingView

Medicamen Biotech Share Key Metrics

Volume

86881.00

Market Cap

310.55 CR

LTQ@LTP

2@228.97

ATP

233.08 Var Margin

22.34 %

Circuit Range

185.32-277.96

Delivery %

58.74 %

Value

2.03 CR

ASM/GSM

No

Market Lot

1

Summary

At 2 Apr, 2026 | 15:48, Medicamen Biotech share price stands at ₹228.97, showing a 2.67% -1.15 for the day. The stock’s intraday movement has stayed between ₹225.01 and ₹239.39, while on a 52-week basis it has fluctuated from ₹216.95 to ₹544.00.

In terms of trading activity, Medicamen Biotech has recorded a volume of 86881 shares, with a market capitalisation of ₹13562815. The stock’s Average Traded Price (ATP) stands at ₹23308, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2,22897. The stock operates within a circuit range of ₹185.32-277.96, with a Value of ₹2.03 CR. The Delivery Percentage for the day is 58.74%. Additionally, Medicamen Biotech currently falls under the No framework, and trades with a market lot size of 1.

Medicamen Biotech Fundamentals

P/E Ratio

33.23

P/B Ratio

1.16

Div. Yield

0.43

Sector P/E

60.59

Sector P/B

3.25

Sec. Div. Yield

0.59

Medicamen Biotech Resistance and Support

Pivot 236.21

Resistance

First Resistance

245.42

Second Resistance

259.21

Third Resistance

268.42

Support

First Support

222.42

Second Support

213.21

Third Support

199.42

Medicamen Biotech Futures & Options

Data Not Found

Medicamen Biotech Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26

Total Promoters

Segment

Percent

Total Promoters

40.46%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.02%

Domestic Institutional Investors

0.49%

Retail

59.03%

Others

0%

Total Promoters

MAR '25

43.16%

JUN '25

40.46%

SEP '25

40.46%

DEC '25

40.46%

Medicamen Biotech Corporate Actions

Date	Agenda
2026-02-13	Quarterly Results
2025-11-14	Quarterly Results
2025-08-12	Quarterly Results
2025-05-30	Audited Results & Final Dividend
2025-02-26	Preferential issue of shares
2025-02-11	Quarterly Results

Medicamen Biotech News

About Medicamen Biotech

NSE : 6278

BSE : 531146

ISIN : INE646B01010

MBL was incorporated as a public limited company under the Companies Act 1956 on December 22 1993. The certificate of commencement of business was obtained on January 31 1994. The company has jointly been promoted by Mr.V.Kumar Mr.Bal Kishan Gupta Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh.MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst Cadila Hindustan Ciba Purepharma Oboi Labs etc. and exporting to countries like Germany Russia Holland CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales.MBL has obtained permission for production of tablets capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited New Delhi and Pure Pharma Private Limited Indore respectively.

Name	Position
Mr. Rahul Bishnoi	Chairman
Mr. Ashwani Kumar Sharma	Non Executive Director

Medicamen Biotech Similar Stocks

Zim Laboratories Ltd.

67.47

3.09 (4.80%)

Osel Devices Ltd.

515.25

-0.20 (0.04%)

Valiant Laboratories Ltd.

57.19

0.25 (0.44%)

Bafna Pharmaceuticals Ltd.

111.32

-0.64 (0.57%)

Medicamen Biotech FAQs

The Buying Price of Medicamen Biotech share is 228.97 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Medicamen Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Medicamen Biotech, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Medicamen Biotech shares is 33.23. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Medicamen Biotech shares is 1.16. Useful to assess the stock's value relative to its book value.

To assess Medicamen Biotech’s valuation compare Sector P/E, P/B which are 60.59 & 3.25 with sector averages, along with growth rates and financial metrics.

The Market Cap of Medicamen Biotech is 310.55 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Medicamen Biotech share price is 544.00 & 216.95. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Medicamen Biotech belongs to the Healthcare sector.